SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000906344-99-000030
Filing Date
1999-07-30
Accepted
1999-07-30 00:00:00
Documents
1
Group Members
YAMANOUCHI GROUP HOLDING INC.YAMANOUCHI PHARMACEUTICAL CO LTD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13D SC 13D/A 7439
  Complete submission text file 0000906344-99-000030.txt   9446
Mailing Address 4 INDUSTRIAL WAY WEST 4 INDUSTRIAL WAY WEST EATONTOWN NJ 07755
Business Address MERIDIAN CENTER II 4 INDUSTRIAL WAY W EATONTOWN NJ 07724 7326761200
ROBERTS PHARMACEUTICAL CORP (Subject) CIK: 0000853022 (see all company filings)

IRS No.: 222429994 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40691 | Film No.: 99675112
SIC: 2834 Pharmaceutical Preparations

Mailing Address 311 NIHONBASHI HONCHO 2 CHOME CHUO-KU TOKYO JAPAN M0
Business Address 311 NILHONBASHI HONCHO 2 CHOME CHUO-KU TOKOYO 103 JAPAN
YAMANOUCHI PHARMACEUTICAL CO LTD (Filed by) CIK: 0000905462 (see all company filings)